{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:59:43Z","timestamp":1790837983980,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373955"],"award-info":[{"award-number":["82373955"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373921"],"award-info":[{"award-number":["82373921"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117236","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:51:34Z","timestamp":1755100294000},"page":"117236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["5-O-Methylvisammioside, a novel inhibitor of CNT2, improves hyperuricemia by inhibiting intestinal purine nucleoside absorption with a safe profile"],"prefix":"10.1016","volume":"242","author":[{"given":"Suiqing","family":"Mai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zean","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2475-1349","authenticated-orcid":false,"given":"Qun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117236_b0005","doi-asserted-by":"crossref","unstructured":"N. Dalbeth, A.L. Gosling, A. Gaffo, A. Abhishek, Gout, Lancet. 397 (2021) 1843-1855.","DOI":"10.1016\/S0140-6736(21)00569-9"},{"key":"10.1016\/j.bcp.2025.117236_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5817348","article-title":"Research advances in the Mechanisms of Hyperuricemia-Induced Renal Injury","volume":"2020","author":"Su","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2025.117236_b0015","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1080\/07853890.2022.2083670","article-title":"Prevalence and related factors of hyperuricaemia in Chinese children and adolescents: a pooled analysis of 11 population-based studies","volume":"54","author":"Rao","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.bcp.2025.117236_b0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1559827615601973","article-title":"Nonpharmacological Management of Gout and Hyperuricemia: Hints for Better Lifestyle","volume":"11","author":"Kakutani-Hatayama","year":"2017","journal-title":"Am. J. Lifestyle Med."},{"key":"10.1016\/j.bcp.2025.117236_b0025","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular Safety of Febuxostat or Allopurinol in patients with Gout","volume":"378","author":"White","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117236_b0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s42358-019-0080-x","article-title":"Benzbromarone in the treatment of gout","volume":"59","author":"Azevedo","year":"2019","journal-title":"Adv Rheumatol."},{"key":"10.1016\/j.bcp.2025.117236_b0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.ajkd.2013.02.378","article-title":"Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis","volume":"62","author":"Lopez-Olivo","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bcp.2025.117236_b0040","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1681\/ASN.0000000000000326","article-title":"Combination Treatment with Verinurad and Allopurinol in CKD: a Randomized Placebo and active Controlled Trial","volume":"35","author":"Heerspink","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2025.117236_b0045","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/13543776.2019.1676727","article-title":"Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016-2019)","volume":"29","author":"Dong","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bcp.2025.117236_b0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","article-title":"From purines to purinergic signalling: molecular functions and human diseases","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.117236_b0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.mam.2012.05.007","article-title":"The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29","volume":"34","author":"Young","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bcp.2025.117236_b0060","first-page":"G1314","article-title":"Sodium-dependent nucleoside transport in the human intestinal brush-border membrane","volume":"272","author":"Patil","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bcp.2025.117236_b0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.phrs.2007.06.005","article-title":"Comparative gene expression profiles of intestinal transporters in mice, rats and humans","volume":"56","author":"Kim","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117236_b0070","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1080\/00498250802069096","article-title":"SLC28 genes and concentrative nucleoside transporter (CNT) proteins","volume":"38","author":"Pastor-Anglada","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2025.117236_b0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2012.06.015","article-title":"Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides","volume":"690","author":"Hiratochi","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117236_b0080","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1021\/acs.jmedchem.5b01884","article-title":"Identification of Adenine and Benzimidazole Nucleosides as Potent Human Concentrative Nucleoside Transporter 2 Inhibitors: potential Treatment for Hyperuricemia and Gout","volume":"59","author":"Tatani","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117236_b0085","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1021\/ml500343r","article-title":"Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors","volume":"6","author":"Tatani","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2025.117236_b0090","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bmcl.2008.11.112","article-title":"Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors","volume":"19","author":"Gupte","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2025.117236_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153348","article-title":"The protective effect of 5-O-methylvisammioside on LPS-induced depression in mice by inhibiting the over activation of BV-2 microglia through Nf-kappaB\/IkappaB-alpha pathway","volume":"79","author":"Sun","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2025.117236_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105444","article-title":"Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation","volume":"117","author":"Chen","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bcp.2025.117236_b0105","doi-asserted-by":"crossref","first-page":"26675","DOI":"10.1074\/jbc.M513421200","article-title":"Molecular determinants of specificity for synthetic nucleoside analogs in the concentrative nucleoside transporter, CNT2","volume":"281","author":"Owen","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117236_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127842","article-title":"Identification of a Staphylococcus aureus amidase catalytic domain inhibitor to prevent biofilm formation by sequential virtual screening, molecular dynamics simulation and biological evaluation","volume":"254","author":"Morris","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2025.117236_b0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/molpharm.120.000169","article-title":"Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 using Functional Knockout Cell Lines and Bayesian Modeling","volume":"99","author":"Miller","year":"2021","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117236_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108108","article-title":"Discovery of cyanidin-3-O-galactoside as a novel CNT2 inhibitor for the treatment of hyperuricemia","volume":"154","author":"Zheng","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bcp.2025.117236_b0125","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00424-003-1107-y","article-title":"The concentrative nucleoside transporter family, SLC28","volume":"447","author":"Gray","year":"2004","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bcp.2025.117236_b0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0005-2787(78)90248-4","article-title":"Metabolic fate of pyrimidines and purines in dietary nucleic acids ingested by mice","volume":"521","author":"Sonoda","year":"1978","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2025.117236_b0135","article-title":"The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117236_b0140","doi-asserted-by":"crossref","first-page":"39884","DOI":"10.1038\/srep39884","article-title":"Soluble Uric Acid Activates the NLRP3 Inflammasome","volume":"7","author":"Braga","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117236_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 Inflammasome: an Overview of Mechanisms of Activation and Regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117236_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190194","article-title":"Intestinal tract is an important organ for lowering serum uric acid in rats","volume":"12","author":"Yun","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117236_b0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03174089","article-title":"Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling","volume":"63","author":"Pastor-Anglada","year":"2007","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.bcp.2025.117236_b0160","first-page":"1461","article-title":"Nucleoside transporters: biological insights and therapeutic applications, Future","volume":"4","author":"Choi","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.bcp.2025.117236_b0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10555-007-9044-4","article-title":"The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs","volume":"26","author":"Zhang","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bcp.2025.117236_b0170","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fphar.2018.00627","article-title":"Who is who in Adenosine Transport","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117236_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108615","article-title":"Uric acid in health and disease: from physiological functions to pathogenic mechanisms","volume":"256","author":"Wen","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117236_b0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1432-1033.1970.tb00813.x","article-title":"Urate oxidase in primate phylogenesis","volume":"12","author":"Christen","year":"1970","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcp.2025.117236_b0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0254-6272(16)30028-0","article-title":"Uric acid lowering effect of Tibetan Medicine RuPeng15 powder in animal models of hyperuricemia","volume":"36","author":"Kou","year":"2016","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.bcp.2025.117236_b0190","article-title":"Yeast to Study Human Purine Metabolism Diseases","volume":"8","author":"Daignan-Fornier","year":"2019","journal-title":"Cells-Basel"},{"key":"10.1016\/j.bcp.2025.117236_b0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41584-019-0222-x","article-title":"Mouse models for human hyperuricaemia: a critical review","volume":"15","author":"Lu","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2025.117236_b0200","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3181\/00379727-157-40002","article-title":"Oxonate-induced hyperuricemia and orotic aciduria in mice","volume":"157","author":"Mangoff","year":"1978","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.bcp.2025.117236_b0205","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.22254","article-title":"Link between high-affinity adenosine concentrative nucleoside transporter-2 (CNT2) and energy metabolism in intestinal and liver parenchymal cells","volume":"225","author":"Huber-Ruano","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2025.117236_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116689","article-title":"Jing-Fang n-butanol extract and its isolated JFNE-C inhibit ferroptosis and inflammation in LPS induced RAW264.7 macrophages via STAT3\/p53\/SLC7A11 signaling pathway","volume":"316","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2025.117236_b0215","first-page":"457","article-title":"Comparative pharmacokinetics of six components in normal and rheumatoid arthritis rats after intragastrical administration of Qianghuo Shengshi Decoction granules by LC-MS\/MS","volume":"16","author":"Li","year":"2024","journal-title":"Chin. Herb. Med."},{"key":"10.1016\/j.bcp.2025.117236_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117048","article-title":"The investigation of potential mechanism of Fuzhengkangfu Decoction against Diabetic myocardial injury based on a combined strategy of network pharmacology, transcriptomics, and experimental verification","volume":"177","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2025.117236_b0225","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013108","article-title":"Relationship between oxidative stress and inflammation in hyperuricemia: Analysis based on asymptomatic young patients with primary hyperuricemia","volume":"97","author":"Zhou","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bcp.2025.117236_b0230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tem.2022.01.002","article-title":"Gut barrier disruption and chronic disease","volume":"33","author":"Martel","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bcp.2025.117236_b0235","doi-asserted-by":"crossref","first-page":"G484","DOI":"10.1152\/ajpgi.00151.2019","article-title":"Hyperuricemia is associated with impaired intestinal permeability in mice","volume":"317","author":"Xu","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcp.2025.117236_b0240","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/08820139.2013.864667","article-title":"Pro-inflammatory effects of uric acid in the gastrointestinal tract","volume":"43","author":"Crane","year":"2014","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.bcp.2025.117236_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155550","article-title":"Multi-omics reveals that 5-O-methylvisammioside prevention acute liver injury in mice by regulating the TNF\/MAPK\/NF-kappaB\/arachidonic acid pathway","volume":"128","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2025.117236_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212394","article-title":"Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis","volume":"22","author":"Kimura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117236_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108361","article-title":"NOX4 promotes mucosal barrier injury in inflammatory bowel disease by mediating macrophages M1 polarization through ROS","volume":"104","author":"Han","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2025.117236_b0260","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2147\/DDDT.S356307","article-title":"Palmatine Protects against MSU-Induced Gouty Arthritis via Regulating the NF-kappaB\/NLRP3 and Nrf2 Pathways","volume":"16","author":"Cheng","year":"2022","journal-title":"Drug Des. Devel. Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:57:34Z","timestamp":1772805454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225005015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"alternative-id":["S0006295225005015"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117236","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-O-Methylvisammioside, a novel inhibitor of CNT2, improves hyperuricemia by inhibiting intestinal purine nucleoside absorption with a safe profile","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117236"}}